$15.4 Billion is the total value of Perceptive Advisors's 299 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 36.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRTX | Buy | MIRATI THERAPEUTICS INC | $1,029,236,000 | +72.9% | 6,371,796 | +83.4% | 6.68% | -11.2% |
BBIO | Buy | BRIDGEBIO PHARMA INC | $945,724,000 | +97.9% | 15,513,856 | +100.0% | 6.14% | +1.6% |
SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $799,362,000 | +124.0% | 9,699,824 | +100.0% | 5.19% | +15.1% |
Buy | RETROPHIN INCnote 2.500% 9/1 | $768,844,000 | +61.9% | 90,000,000 | +100.0% | 4.99% | -16.8% | |
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $570,346,000 | +108.2% | 21,919,544 | +153.4% | 3.70% | +6.9% |
FOLD | Buy | AMICUS THERAPEUTICS INC | $445,780,000 | +97.4% | 46,242,658 | +102.3% | 2.90% | +1.4% |
Buy | COLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1 | $379,446,000 | +100.2% | 35,000,000 | +100.0% | 2.46% | +2.8% | |
HZNP | Buy | HORIZON THERAPEUTICS PUB L | $371,750,000 | +97.0% | 3,970,004 | +93.7% | 2.41% | +1.2% |
VBIV | Buy | VBI VACCINES INC CDA | $368,784,000 | +115.4% | 110,084,930 | +100.0% | 2.40% | +10.6% |
LABP | Buy | LANDOS BIOPHARMA INC | $343,494,000 | +143.7% | 29,739,830 | +100.0% | 2.23% | +25.1% |
NVTA | Buy | INVITAE CORP | $325,076,000 | +58.7% | 9,637,602 | +79.8% | 2.11% | -18.5% |
Buy | NEVRO CORPnote 2.750% 4/0 | $312,552,000 | +131.0% | 18,000,000 | +100.0% | 2.03% | +18.6% | |
ZYME | Buy | ZYMEWORKS INC | $298,722,000 | +118.4% | 8,611,200 | +98.8% | 1.94% | +12.1% |
GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $290,854,000 | +41.1% | 8,305,378 | +64.2% | 1.89% | -27.5% |
NVRO | Buy | NEVRO CORP | $271,484,000 | +139.6% | 1,637,520 | +101.6% | 1.76% | +23.0% |
RCKT | Buy | ROCKET PHARMACEUTICALS INC | $243,736,000 | +91.6% | 5,503,206 | +91.9% | 1.58% | -1.6% |
OM | Buy | OUTSET MED INC | $238,658,000 | +83.8% | 4,775,070 | +100.0% | 1.55% | -5.6% |
CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $237,912,000 | +273.2% | 9,286,190 | +100.0% | 1.54% | +91.7% |
ALDX | Buy | ALDEYRA THERAPEUTICS INC | $224,422,000 | +117.0% | 19,807,758 | +127.6% | 1.46% | +11.5% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $221,320,000 | +656.1% | 1,233,604 | +604.9% | 1.44% | +288.4% |
MGTX | Buy | MEIRAGTX HLDGS PLC | $215,396,000 | +130.7% | 13,896,554 | +100.4% | 1.40% | +18.5% |
NAUT | New | NAUTILUS BIOTECHNOLOGY INC | $180,004,000 | – | 17,822,302 | +100.0% | 1.17% | – |
CCCC | Buy | C4 THERAPEUTICS INC | $170,928,000 | +46.3% | 4,517,132 | +43.0% | 1.11% | -24.8% |
OMIC | New | SINGULAR GENOMICS SYSTEMS IN | $169,434,000 | – | 6,165,740 | +100.0% | 1.10% | – |
ALBO | Buy | ALBIREO PHARMA INC | $166,060,000 | +99.6% | 4,720,278 | +100.0% | 1.08% | +2.6% |
RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $162,786,000 | +194.1% | 6,628,064 | +100.0% | 1.06% | +51.0% |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $158,014,000 | +72.5% | 1,623,664 | +72.4% | 1.03% | -11.4% |
RAPT | Buy | RAPT THERAPEUTICS INC | $157,402,000 | +186.2% | 4,951,320 | +99.9% | 1.02% | +46.8% |
CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $149,424,000 | +189.5% | 7,927,034 | +116.6% | 0.97% | +48.5% |
RLAY | Buy | RELAY THERAPEUTICS INC | $147,684,000 | +111.7% | 4,036,194 | +100.0% | 0.96% | +8.7% |
BEAM | Buy | BEAM THERAPEUTICS INC | $138,398,000 | +265.8% | 1,075,270 | +100.0% | 0.90% | +88.1% |
ZY | New | ZYMERGEN INC | $130,698,000 | – | 3,266,664 | +100.0% | 0.85% | – |
CHRS | Buy | COHERUS BIOSCIENCES INC | $129,936,000 | +89.3% | 9,395,224 | +100.0% | 0.84% | -2.8% |
ATNX | Buy | ATHENEX INC | $125,040,000 | +118.1% | 27,064,934 | +100.0% | 0.81% | +12.0% |
ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $122,348,000 | +98.2% | 1,400,816 | +41.9% | 0.80% | +1.8% |
KDMN | Buy | KADMON HLDGS INC | $121,606,000 | +99.0% | 31,422,668 | +100.0% | 0.79% | +2.2% |
KRON | Buy | KRONOS BIO INC | $121,094,000 | +52.0% | 5,056,104 | +81.9% | 0.79% | -22.0% |
QTNT | Buy | QUOTIENT LTD | $117,942,000 | +97.8% | 32,401,636 | +100.0% | 0.77% | +1.6% |
MGNX | Buy | MACROGENICS INC | $115,394,000 | +68.7% | 4,296,120 | +100.0% | 0.75% | -13.4% |
MDT | New | MEDTRONIC PLC | $111,716,000 | – | 900,000 | +100.0% | 0.73% | – |
MORF | Buy | MORPHIC HLDG INC | $107,680,000 | +81.4% | 1,876,280 | +100.0% | 0.70% | -6.9% |
SLDB | Buy | SOLID BIOSCIENCES INC | $98,180,000 | +32.4% | 26,825,104 | +100.0% | 0.64% | -32.0% |
AVIR | Buy | ATEA PHARMACEUTICALS INC | $97,056,000 | -47.5% | 4,518,448 | +45.3% | 0.63% | -73.0% |
New | COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $92,106,000 | – | 9,000,000 | +100.0% | 0.60% | – | |
CMAX | New | CAREMAX INC | $85,656,000 | – | 6,640,000 | +100.0% | 0.56% | – |
DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $84,034,000 | +104.9% | 15,391,010 | +100.0% | 0.55% | +5.2% |
APLS | New | APELLIS PHARMACEUTICALS INC | $83,570,000 | – | 1,322,324 | +100.0% | 0.54% | – |
VRCA | Buy | VERRICA PHARMACEUTICALS INC | $81,596,000 | +49.2% | 7,220,824 | +100.0% | 0.53% | -23.4% |
RAIN | New | RAIN THERAPEUTICS INC | $78,850,000 | – | 5,074,038 | +100.0% | 0.51% | – |
TMCI | New | TREACE MED CONCEPTS INC | $77,268,000 | – | 2,471,772 | +100.0% | 0.50% | – |
TARS | Buy | TARSUS PHARMACEUTICALS INC | $75,140,000 | +82.7% | 2,592,832 | +100.0% | 0.49% | -6.2% |
AXSM | New | AXSOME THERAPEUTICS INC | $74,734,000 | – | 1,107,816 | +100.0% | 0.48% | – |
VERU | Buy | VERU INC | $71,844,000 | +49.8% | 8,902,684 | +100.0% | 0.47% | -23.1% |
ATHA | Buy | ATHIRA PHARMA INC | $70,162,000 | +11.3% | 6,851,832 | +100.0% | 0.46% | -42.8% |
HCAT | Buy | HEALTH CATALYST INC | $62,846,000 | +165.5% | 1,132,168 | +123.7% | 0.41% | +36.5% |
XENE | Buy | XENON PHARMACEUTICALS INC | $62,524,000 | +578.2% | 3,357,946 | +552.0% | 0.41% | +247.0% |
DRNA | Buy | DICERNA PHARMACEUTICALS INC | $59,712,000 | +191.9% | 1,600,000 | +100.0% | 0.39% | +49.8% |
IMTX | Buy | IMMATICS N.V | $58,050,000 | +107.1% | 5,000,000 | +100.0% | 0.38% | +6.5% |
EXAS | Buy | EXACT SCIENCES CORP | $58,058,000 | +24.6% | 467,046 | +32.1% | 0.38% | -36.0% |
BCAB | New | BIOATLA INC | $58,104,000 | – | 1,371,038 | +100.0% | 0.38% | – |
NARI | Buy | INARI MED INC | $57,916,000 | -4.2% | 620,874 | +9.9% | 0.38% | -50.8% |
ISEE | Buy | IVERIC BIO INC | $57,870,000 | +104.2% | 9,171,024 | +100.0% | 0.38% | +5.0% |
XLRN | New | ACCELERON PHARMA INC | $56,912,000 | – | 453,520 | +100.0% | 0.37% | – |
NUVB | Buy | NUVATION BIO INC | $56,624,000 | +95.0% | 6,082,008 | +100.0% | 0.37% | +0.3% |
ATEC | Buy | ALPHATEC HLDGS INC | $55,158,000 | +116.4% | 3,600,360 | +100.0% | 0.36% | +11.2% |
TVTX | Buy | TRAVERE THERAPEUTICS INC | $53,854,000 | -34.6% | 3,691,110 | +11.9% | 0.35% | -66.4% |
GRPH | New | GRAPHITE BIO INC | $53,784,000 | – | 1,750,186 | +100.0% | 0.35% | – |
RNA | Buy | AVIDITY BIOSCIENCES INC | $53,326,000 | +122.5% | 2,158,056 | +96.4% | 0.35% | +14.2% |
KOD | Buy | KODIAK SCIENCES INC | $53,204,000 | +20.6% | 572,082 | +47.1% | 0.35% | -38.0% |
ADMA | Buy | ADMA BIOLOGICS INC | $53,072,000 | +81.8% | 33,169,604 | +100.0% | 0.34% | -6.5% |
RGEN | New | REPLIGEN CORP | $52,900,000 | – | 265,000 | +100.0% | 0.34% | – |
ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $52,200,000 | +92.3% | 630,282 | +54.0% | 0.34% | -1.2% |
LYRA | Buy | LYRA THERAPEUTICS INC | $51,754,000 | +38.6% | 6,445,120 | +100.0% | 0.34% | -28.8% |
COGT | Buy | COGENT BIOSCIENCES INC | $51,722,000 | +84.7% | 6,377,500 | +100.0% | 0.34% | -5.1% |
PMVP | Buy | PMV PHARMACEUTICALS INC | $51,004,000 | +107.7% | 1,493,114 | +100.0% | 0.33% | +6.4% |
INBX | New | INHIBRX INC | $49,926,000 | – | 1,814,180 | +100.0% | 0.32% | – |
CLDX | New | CELLDEX THERAPEUTICS INC NEW | $49,672,000 | – | 1,485,398 | +100.0% | 0.32% | – |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $46,252,000 | +99.5% | 1,956,554 | +100.0% | 0.30% | +2.4% |
FBRX | Buy | FORTE BIOSCIENCES INC | $46,060,000 | +96.2% | 1,370,000 | +100.0% | 0.30% | +0.7% |
STOK | Buy | STOKE THERAPEUTICS INC | $45,238,000 | +73.3% | 1,343,956 | +100.0% | 0.29% | -10.9% |
AGRX | Buy | AGILE THERAPEUTICS INC | $42,348,000 | +27.9% | 31,839,850 | +100.0% | 0.28% | -34.4% |
VYNE | Buy | VYNE THERAPEUTICS INC | $40,534,000 | -12.6% | 11,547,908 | +70.5% | 0.26% | -55.1% |
ONCR | Buy | ONCORUS INC | $40,396,000 | +45.8% | 2,927,198 | +47.1% | 0.26% | -25.1% |
CLOV | Buy | CLOVER HEALTH INVESTMENTS CO | $39,960,000 | +287.1% | 3,000,000 | +100.0% | 0.26% | +98.5% |
VRNA | Buy | VERONA PHARMA PLCsponsored ads | $37,786,000 | +56.5% | 5,777,778 | +100.0% | 0.24% | -19.7% |
DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $34,430,000 | – | 1,512,094 | +100.0% | 0.22% | – |
ONEM | Buy | 1LIFE HEALTHCARE INC | $34,120,000 | +68.0% | 1,032,088 | +98.5% | 0.22% | -13.6% |
CMIIU | Buy | CM LIFE SCIENCES II INCunit 02/25/2028 | $33,626,000 | +110.2% | 2,500,000 | +100.0% | 0.22% | +7.9% |
TDOC | New | TELADOC HEALTH INCcall | $33,258,000 | – | 200,000 | +100.0% | 0.22% | – |
Buy | CATABASIS PHARMACEUTICALS IN | $32,438,000 | +480.5% | 15,374,370 | +695.1% | 0.21% | +197.2% | |
New | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $32,388,000 | – | 2,000,000 | +100.0% | 0.21% | – | |
IMCR | Buy | IMMUNOCORE HLDGS PLCads | $31,240,000 | +83.5% | 800,000 | +100.0% | 0.20% | -5.6% |
NEPT | Buy | NEPTUNE WELLNESS SOLUTIONS I | $30,068,000 | +81.6% | 25,699,412 | +100.0% | 0.20% | -6.7% |
ACRS | Buy | ACLARIS THERAPEUTICS INC | $29,852,000 | +82.2% | 1,700,000 | +161.5% | 0.19% | -6.3% |
HCAQ | Buy | HEALTHCOR CATALIO ACQU CORPcl a shrs | $29,550,000 | +98.6% | 3,000,000 | +100.0% | 0.19% | +2.1% |
NBTX | Buy | NANOBIOTIX SAsponsored ads | $29,208,000 | +83.2% | 2,119,600 | +100.0% | 0.19% | -5.9% |
VRDN | New | VIRIDIAN THERAPEUTICS INC | $29,062,000 | – | 1,589,012 | +100.0% | 0.19% | – |
ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $28,832,000 | +103.0% | 705,608 | +100.0% | 0.19% | +3.9% |
FUSN | Buy | FUSION PHARMACEUTICALS INC | $28,686,000 | +37.2% | 3,550,334 | +82.1% | 0.19% | -29.5% |
VTRS | Buy | VIATRIS INC | $28,706,000 | +104.6% | 2,008,838 | +100.0% | 0.19% | +5.1% |
LPTX | Buy | LEAP THERAPEUTICS INC | $27,802,000 | +72.6% | 16,952,992 | +100.0% | 0.18% | -11.3% |
HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $27,740,000 | +169.4% | 982,664 | +215.3% | 0.18% | +38.5% |
CMLTU | New | CM LIFE SCIENCES III INCunit 04/30/2028 | $27,376,000 | – | 2,500,000 | +100.0% | 0.18% | – |
ACCD | Buy | ACCOLADE INC | $26,692,000 | +70.2% | 491,482 | +42.2% | 0.17% | -12.6% |
CVRX | New | CVRX INC | $24,640,000 | – | 880,000 | +100.0% | 0.16% | – |
BLSA | Buy | BCLS ACQUISITION CORP | $21,060,000 | +99.2% | 2,000,000 | +100.0% | 0.14% | +2.2% |
CTMX | Buy | CYTOMX THERAPEUTICS INC | $20,774,000 | +24.8% | 3,281,914 | +52.4% | 0.14% | -36.0% |
RACB | Buy | RESEARCH ALLIANCE CORP II | $20,280,000 | +97.9% | 2,000,000 | +100.0% | 0.13% | +1.5% |
SMIHU | New | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $20,020,000 | – | 2,000,000 | +100.0% | 0.13% | – |
DNAY | New | CODEX DNA INC | $18,700,000 | – | 850,000 | +100.0% | 0.12% | – |
CNCE | Buy | CONCERT PHARMACEUTICALS INC | $18,150,000 | +69.1% | 4,301,282 | +100.0% | 0.12% | -13.2% |
FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $18,072,000 | -6.4% | 750,512 | +68.7% | 0.12% | -52.0% |
PRVB | Sell | PROVENTION BIO INC | $15,992,000 | -46.6% | 1,896,962 | -33.5% | 0.10% | -72.6% |
PSTX | Buy | POSEIDA THERAPEUTICS INC | $15,786,000 | +109.8% | 1,575,490 | +100.0% | 0.10% | +8.4% |
RACA | THERAPEUTICS ACQUISITION COR | $15,405,000 | -2.3% | 1,500,000 | 0.0% | 0.10% | -49.7% | |
ACHL | Buy | ACHILLES THERAPEUTICS PLCsponsored ads | $14,790,000 | +18.3% | 1,510,750 | +100.0% | 0.10% | -39.2% |
SILK | Sell | SILK RD MED INC | $14,084,000 | -18.2% | 294,266 | -13.5% | 0.09% | -58.3% |
Buy | DARIOHEALTH CORP | $14,006,000 | +121.8% | 655,738 | +100.0% | 0.09% | +13.8% | |
TSHA | Buy | TAYSHA GENE THERAPIES INC | $13,586,000 | +42.3% | 640,880 | +36.2% | 0.09% | -27.3% |
PRVA | New | PRIVIA HEALTH GROUP INC | $11,980,000 | – | 270,000 | +100.0% | 0.08% | – |
AKYA | New | AKOYA BIOSCIENCES INC | $11,604,000 | – | 600,000 | +100.0% | 0.08% | – |
BCTG | Buy | BCTG ACQUISITION CORP | $11,380,000 | +104.7% | 1,000,000 | +100.0% | 0.07% | +5.7% |
MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $10,754,000 | -46.8% | 3,392,136 | -43.5% | 0.07% | -72.7% |
CHFWU | Buy | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $10,400,000 | +113.1% | 1,000,000 | +100.0% | 0.07% | +9.7% |
PRTA | New | PROTHENA CORP PLC | $10,282,000 | – | 200,000 | +100.0% | 0.07% | – |
LGVU | Buy | LONGVIEW ACQUISITION CORP IIunit 99/99/9999 | $10,080,000 | +100.8% | 1,000,000 | +100.0% | 0.06% | +3.2% |
HSAQ | Buy | HEALTH SCIENCES ACQ CORP 2 | $9,180,000 | +82.3% | 900,000 | +100.0% | 0.06% | -6.2% |
TARA | Buy | PROTARA THERAPEUTICS INC | $8,214,000 | +23.8% | 843,282 | +100.0% | 0.05% | -36.9% |
MRUS | Buy | MERUS NV | $7,374,000 | +101.8% | 350,000 | +100.0% | 0.05% | +4.3% |
AMWL | Buy | AMERICAN WELL CORPcl a | $7,296,000 | +18.3% | 580,000 | +63.4% | 0.05% | -39.7% |
RGNX | Buy | REGENXBIO INC | $6,938,000 | +193.6% | 178,566 | +157.7% | 0.04% | +50.0% |
CMLF | Buy | CM LIFE SCIENCES INC | $6,360,000 | +236.3% | 454,000 | +257.5% | 0.04% | +70.8% |
FULC | New | FULCRUM THERAPEUTICS INC | $6,164,000 | – | 588,236 | +100.0% | 0.04% | – |
LSAQ | Buy | LIFESCI ACQUISITION II CORP | $6,000,000 | +97.2% | 600,000 | +100.0% | 0.04% | +2.6% |
GRTX | Buy | GALERA THERAPEUTICS INC | $5,006,000 | +122.9% | 509,328 | +100.0% | 0.03% | +17.9% |
FREQ | Sell | FREQUENCY THERAPEUTICS INC | $4,426,000 | -78.0% | 444,444 | -79.0% | 0.03% | -88.6% |
CEREW | Buy | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $3,828,000 | +568.1% | 266,132 | +100.0% | 0.02% | +257.1% |
MOTS | Buy | MOTUS GI HLDGS INC | $3,746,000 | +81.0% | 3,601,084 | +100.0% | 0.02% | -7.7% |
SRRA | Buy | SIERRA ONCOLOGY INC | $2,596,000 | +126.1% | 133,310 | +100.0% | 0.02% | +13.3% |
RACE | Buy | FERRARI N V | $2,556,000 | +96.9% | 12,400 | +100.0% | 0.02% | +6.2% |
SGTX | Buy | SIGILON THERAPEUTICS INC | $2,682,000 | -4.0% | 250,000 | +100.0% | 0.02% | -51.4% |
EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $2,384,000 | +92.6% | 279,780 | +100.0% | 0.02% | -6.2% |
BFLYWS | Buy | BUTTERFLY NETWORK INC*w exp 02/12/202 | $2,254,000 | +49.8% | 466,666 | +100.0% | 0.02% | -21.1% |
SCPEWS | Buy | SC HEALTH CORP*w exp 99/99/999 | $2,110,000 | +123.3% | 1,000,000 | +100.0% | 0.01% | +16.7% |
PLXP | Sell | PLX PHARMA INC | $1,586,000 | -20.9% | 114,918 | -48.3% | 0.01% | -60.0% |
TKNO | New | ALPHA TEKNOVA INC | $1,424,000 | – | 60,000 | +100.0% | 0.01% | – |
PHVS | Buy | PHARVARIS NV | $1,006,000 | +33.2% | 54,000 | +100.0% | 0.01% | -30.0% |
TCRR | Sell | TCR2 THERAPEUTICS INC | $1,010,000 | -85.4% | 61,506 | -80.4% | 0.01% | -92.0% |
CMAXW | New | CAREMAX INC*w exp 06/08/202 | $566,000 | – | 120,000 | +100.0% | 0.00% | – |
RAPT | New | RAPT THERAPEUTICS INCput | $166,000 | – | 90,000 | +100.0% | 0.00% | – |
DFHT | Exit | DEERFIELD HEALTHCARE TECH AC | $0 | – | -20,000 | -100.0% | -0.00% | – |
SANA | Exit | SANA BIOTECHNOLOGY INC | $0 | – | -10,000 | -100.0% | -0.00% | – |
CVM | Exit | CEL-SCI CORP | $0 | – | -33,700 | -100.0% | -0.01% | – |
VINCW | Exit | VINCERX PHARMA INC*w exp 12/24/202 | $0 | – | -300,000 | -100.0% | -0.02% | – |
TLIS | Exit | TALIS BIOMEDICAL CORP | $0 | – | -250,000 | -100.0% | -0.04% | – |
VRAY | Exit | VIEWRAY INC | $0 | – | -751,748 | -100.0% | -0.04% | – |
TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -2,750,000 | -100.0% | -0.05% | – |
DFHTU | Exit | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $0 | – | -300,000 | -100.0% | -0.05% | – |
PHR | Exit | PHREESIA INC | $0 | – | -100,000 | -100.0% | -0.07% | – |
VINC | Exit | VINCERX PHARMA INC | $0 | – | -300,000 | -100.0% | -0.07% | – |
SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -270,000 | -100.0% | -0.08% | – |
FGEN | Exit | FIBROGEN INCput | $0 | – | -200,000 | -100.0% | -0.09% | – |
PCVX | Exit | VAXCYTE INC | $0 | – | -850,000 | -100.0% | -0.21% | – |
CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -797,404 | -100.0% | -0.37% | – |
FMTX | Exit | FORMA THERAPEUTICS HOLDINGS | $0 | – | -1,250,000 | -100.0% | -0.44% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,410,305 | -100.0% | -0.46% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -575,007 | -100.0% | -0.50% | – |
ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -1,143,790 | -100.0% | -0.51% | – |
BIIB | Exit | BIOGEN INCput | $0 | – | -600,000 | -100.0% | -2.12% | – |
BIIB | Exit | BIOGEN INCcall | $0 | – | -748,000 | -100.0% | -2.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-03-20 |
SC 13G | 2024-03-14 |
SC 13G | 2024-03-11 |
SC 13G/A | 2024-03-06 |
SC 13D/A | 2024-03-01 |
SC 13G | 2024-03-01 |
SC 13D/A | 2024-02-29 |
13F-HR/A | 2024-02-26 |
SC 13G/A | 2024-02-23 |
4 | 2024-02-21 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.